PUBLISHER: The Business Research Company | PRODUCT CODE: 1947039
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947039
Radiotherapy devices are utilized in cancer treatment by delivering high doses of radiation to eliminate cancer cells and reduce tumor size. These devices are designed to target and destroy cancerous cells while minimizing harm to the surrounding healthy tissues. Through techniques such as external beam radiation and brachytherapy, radiotherapy devices play an essential role in the treatment and management of cancer.
The primary product types of radiotherapy devices include external beam radiation therapy devices, linear accelerator devices (LINAC), and proton therapy devices. A medical linear accelerator, or LINAC, is a radiotherapy device typically employed for external beam radiation treatments in cancer patients. It delivers high-energy x-rays or electrons to the specific region of the patient's tumor. These devices find applications in treating various types of cancer, including skin cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, and others. Radiotherapy devices are used in healthcare settings such as hospitals, ambulatory surgical centers, and oncological treatment centers.
Tariffs are impacting the radiotherapy devices market by increasing costs of imported linear accelerators, imaging components, precision sensors, control software, and shielding materials used in advanced radiation systems. Hospitals and oncology centers in North America and Europe are most affected due to reliance on imported high-value medical equipment, while Asia-Pacific faces higher procurement costs for advanced treatment installations. These tariffs are raising capital expenditure requirements and extending procurement timelines. However, they are also encouraging localized manufacturing, regional assembly partnerships, and domestic innovation in radiotherapy device development.
The radiotherapy devices market research report is one of a series of new reports from The Business Research Company that provides radiotherapy devices market statistics, including radiotherapy devices industry global market size, regional shares, competitors with a radiotherapy devices market share, detailed radiotherapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the radiotherapy devices industry. This radiotherapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The radiotherapy devices market size has grown strongly in recent years. It will grow from $6.64 billion in 2025 to $7.21 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rising global cancer incidence rates, expansion of oncology treatment infrastructure, increasing adoption of external beam radiation therapies, improvements in linear accelerator performance, wider availability of advanced radiotherapy techniques.
The radiotherapy devices market size is expected to see strong growth in the next few years. It will grow to $10.18 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to growing demand for personalized cancer treatment, increasing investments in proton therapy centers, expansion of AI-assisted oncology workflows, rising focus on minimizing radiation side effects, continued technological innovation in radiation delivery systems. Major trends in the forecast period include increasing adoption of image-guided radiation therapy systems, rising deployment of proton therapy technologies, growing integration of ai-based treatment planning, expansion of stereotactic radiation techniques, enhanced focus on precision dose delivery.
The rising prevalence of cancer is anticipated to drive the growth of the radiotherapy devices market in the future. Cancer prevalence refers to the total number or proportion of individuals within a population diagnosed with cancer at a specific point in time or over a defined period. Radiotherapy is frequently used as a primary or supportive treatment for newly diagnosed cancer patients. It is employed to shrink tumors, control cancer progression, or destroy cancer cells before or after surgical procedures. For example, in July 2024, the Australian Institute of Health and Welfare, an Australian government agency, reported that the number of cancer cases diagnosed in Australia increased from 160,570 in 2022 to 164,694 in 2023, marking a significant annual rise. This trend underscores the growing prevalence of cancer in the country. Consequently, the increasing prevalence of cancer is driving the demand for radiotherapy devices.
Major companies operating in the radiotherapy devices market are actively innovating new technologies such as The Versa HD to enhance their market profitability. The Versa HD is a linear accelerator system designed for radiation therapy. For instance, in May 2023, the Mitchell Cancer Institute introduced a new radiation technology known as The Versa HD. This system is capable of delivering Volumetric Modulated Arc Therapy (VMAT), which accelerates treatment delivery and enhances the patient's experience. The Versa HD also provides High-Definition Dynamic Radiosurgery (HDRS), equipped with special sequencing capabilities, effectively transforming the linear accelerator into a specialized solution for Stereotactic Radiosurgery (SRS).
In October 2023, Elekta, a Sweden-based provider of radiotherapy devices and oncology treatment solutions, acquired the Xoft Axxent electronic brachytherapy (eBx) system from iCAD, Inc. for $5.5 million. Through this acquisition, Elekta sought to broaden its brachytherapy portfolio and increase the adoption of electronic X-ray-based brachytherapy systems in markets with limited radiation shielding infrastructure. iCAD, Inc. is a US-based company that manufactures radiotherapy devices.
Major companies operating in the radiotherapy devices market are Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, IBA Ion Beam Applications SA, Koninklijke Philips N.V., Siemens Aktiengesellschaft, Eckert & Ziegler Bebig, IsoRay Inc., General Electric Healthcare, Vision RT Ltd., RaySearch Laboratories AB, Theragenics Corporation, Canon Medical Systems Corporation, Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, Neusoft Medical Systems Co. Ltd., Mevion Medical Systems Inc., Optivus Proton Therapy Inc., Panacea Medical Technologies Pvt. Ltd., P-Cure Ltd., Provision Healthcare LLC, Sumitomo Heavy Industries Ltd., ViewRay Inc., Miranda Medical, Nordion Inc., NTP Radioisotopes SOC Ltd., Curium, Hitachi Ltd., Brainlab AG, Best Theratronics Ltd., ProTom International Inc., RefleXion Medical Inc., Insightec Ltd., TomoTherapy Incorporated, Agile MV LLC, CIVCO Radiotherapy, Johari Digital Healthcare Ltd., Alpha Tau Medical Ltd.,
North America was the largest region in the radiotherapy devices market in 2025. Asia-Pacific was the second-largest region in the global radiotherapy devices market report. The regions covered in the radiotherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the radiotherapy devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The radiotherapy devices market consists of sales of external beam radiation therapy devices, linear accelerator devices, and proton therapy devices that are used for radiotherapy. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Radiotherapy Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses radiotherapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for radiotherapy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The radiotherapy devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.